Note 16. Segment Information

12 Months Ended

Jun. 30, 2013

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

Note 16. Segment Information

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into three reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the fiscal years ended June 30, 2013 and 2012 were $12,797 and $12,799, respectively.

Financial information relating to the fiscal years ended June 30, 2013 and 2012 operations by business segment are as follows:

		Sales, Net						Segment
		U.S.		International				Gross				Capital		Total
		Customers		Customers		Total		Profit		Depreciation		Expenditures		Assets
Contract Manufacturing	2013	$	18,331	$	10,978	$	29,309	$	4,626	$	267	$	94	$	8,524
	2012		15,477		9,927		25,404		3,743		306		151		7,412
Branded Proprietary Products	2013		631		1,651		2,282		346		8		1		2,186
	2012		6,011		2,700		8,711		3,239		33		-		2,351
Other Nutraceutical Businesses	2013		1,864		168		2,032		529		13		3		1,901
	2012		2,317		172		2,489		625		20		4		2,114
Total Company	2013		20,826		12,797		33,623		5,501		288		98		12,611
	2012		23,805		12,799		36,604		7,607		359		155		11,877